Q32 BIO PRESENTS RESULTS FROM PART B OF THE SIGNAL-AA CLINICAL TRIAL OF BEMPIKIBART IN ALOPECIA AREATA IN A LATE-BREAKER AT THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY CONGRESS 2026

Reuters · 2d ago

Please log in to view news